Saw Palmetto
Saw palmetto (Serenoa repens) is a plant-derived supplement most commonly used for benign prostatic hyperplasia (BPH) symptoms and, less commonly, for hair loss, due to its reported effects on androgen-related pathways. It contains fatty acids and phytosterols that have been studied for their potential to influence 5-alpha-reductase activity and downstream androgen signaling, which is why it is often discussed alongside pharmaceutical agents like finasteride.
-
This page summarizes anecdotal reports and community observations, not medical evidence. Reports may be incomplete, biased or inaccurate and are not medical advice or recommendations. “Risk” here refers to how frequently severe or prolonged symptom worsening is reported, not to proven causation or population-wide probability. Individual responses vary widely, and absence of issues in some users does not rule out significant reactions in others.
-
Within PFS/PSSD/PAS communities, saw palmetto is discussed in relation to its potential interactions with androgen signaling pathways. In laboratory and preclinical models, various extracts have demonstrated anti-androgen–related activity, including inhibition of 5-alpha-reductase (the enzyme that converts testosterone to DHT) and reduced DHT interaction with the androgen receptor in certain systems. These mechanisms may interact with pathways involving androgen signaling and 5-alpha-reductase that are often discussed in relation to PFS / PSSD / PAS. (pmc 1) (pmc 2)
-
Reports of Severe and Sometimes Lasting Worsening (for PFS/PSSD/PAS):
Among individuals who already have PFS/PSSD/PAS, saw palmetto is approached with significant caution as it is frequently cited in community reports as preceding symptom worsening, with accounts describing both acute exacerbations and longer-lasting declines in baseline. Although the severity and duration of these reactions vary between individuals, reports within this subgroup show a largely consistent direction toward worsening rather than improvement. In light of this pattern, many within the community view saw palmetto as carrying a meaningful risk for those with established PFS/PSSD/PAS, even in the absence of controlled data.
For individuals without these conditions, saw palmetto is widely used and tolerated by many, but there are also reports of a so-called "post–saw palmetto" reaction with symptoms that can resemble PFS/PSSD/PAS.
Evidence basis: Anecdotal reports (online forums, self-reports); preclinical and mechanistic studies; mixed clinical data; no controlled studies examining PFS/PSSD/PAS outcomes.
-
Public comments reflect individual experiences and opinions. They are not medical advice and may not be accurate or representative.